Conclusions
insomnia, anxiety
The present study documented the efficacy of BT and zolpidem for improving daytime functional outcomes among patients with insomnia and the effect of BT on reducing anxiety symptoms. Adding a second treatment offered an added value for further improvements of daytime functions. Future developments of insomnia treatment strategies should take into account the daytime consequences of insomnia. Additional studies are needed to further investigate the potential benefits of switching treatment modalities and incorporating a therapeutic component that can address psychological and mood disturbances.